首页> 外文期刊>American journal of therapeutics >Can a poison center overdose guideline safely reduce pediatric emergency department visits for unintentional β-blocker ingestions?
【24h】

Can a poison center overdose guideline safely reduce pediatric emergency department visits for unintentional β-blocker ingestions?

机译:毒物中心服药过量指南可以安全地减少因无意摄入β受体阻滞剂而导致的儿科急诊就诊吗?

获取原文
获取原文并翻译 | 示例
           

摘要

Poisoning is a leading cause cause for injury and death in pediatric patients. For this reason, β-blocker ingestion has been an indication for emergency department (ED) referral and evaluation in pediatric patients even though significant clinical effects are uncommonly reported. We sought to determine whether an evidence-based triage guideline developed jointly by the American Association of Poison Control Centers, American Academy of Clinical Toxicology, and American College of Medical Toxicology safely reduces unnecessary pediatric ED visits after unintentional small dose β-blocker overdose. This was a prospective study of patients aged 0-6 years with a β-blocker ingestion managed by a regional poison center pre and postimplementation of the triage guideline. One hundred fifty-three cases met inclusion criteria. Before implementation of an evidence-based triage guideline for out-of-hospital management, 52 (67%) cases were referred for ED evaluation, and 26 (33%) cases were recommended for home observation. After guideline implementation, 38 (51%) cases were referred for ED evaluation, and 37 (49%) were recommended for home observation. No deaths occurred in either group. The triage guideline was accurately followed by poison center staff in 96% of cases after implementation. An out-of-hospital triage guideline for pediatric β-blocker overdose was accurately followed by poison center staff and safely reduced unnecessary ED referrals with a 50% increase in home observation.
机译:中毒是小儿患者受伤和死亡的主要原因。因此,即使鲜有临床效果报道,摄入β-受体阻滞剂仍是儿科急诊科(ED)转诊和评估的指征。我们试图确定由美国毒物控制中心协会,美国临床毒理学研究院和美国医学毒理学学会联合制定的循证分诊指南是否可以安全地减少意外的小剂量β-受体阻滞剂过量后不必要的儿科ED访视。这是一项前瞻性研究,研究对象是0-6岁的患者,在分流指南实施前和实施后,由区域毒物中心管理了β受体阻滞剂的摄入。 153例符合纳入标准。在实施针对院外管理的循证分诊指南之前,将52例(67%)病例进行急诊评估,建议26例(33%)病例进行家庭观察。指南实施后,推荐38例(51%)进行ED评估,建议37例(49%)进行家庭观察。两组均未发生死亡。实施后,在96%的案例中,毒物中心的工作人员都严格遵循了分类指南。毒物中心工作人员准确遵循了针对小儿β受体阻滞剂过量的院外分诊指南,并通过减少50%的家庭观察安全地减少了不必要的ED转诊。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号